Methods. In a sub-arctic region at 69º N, seven individuals with selfreported insomnia during the 'dark period' and seven without, were followed with repeated measures of melatonin and questioned on ten different sleep variables, from the beginning of January to the vernal equinox in March.
INTRODUCTION
Seasonal changes in human behaviour and physiology have been recognized since ancient time. With its extreme northern geographical position at 69º N, Tromsø, Northern Norway, provides a unique natural laboratory for studying the effects of season on humans, keeping in mind the influence of artificial light. People living north of the Arctic Circle are exposed to marked seasonal changes in the light-darkness ratio, ranging from the darkness of the "polar night", to constant daylight during the midnight sun period. The sub-arctic climate in Tromsø has special characteristics. In Tromsø, the "darkness period" in wintertime lasts from November 25 until January 17. Due to the surrounding mountains, the sun does not rise above the horizon in the centre of Tromsø from November 22 until January 20. In the middle of this period, there is almost total darkness all day, except for a few hours of dim daylight on clear days around noon. These marginal light conditions have been related to various sleep problems, especially insomnia during the dark period, but also seasonal affective disorder (SAD), or "winter blues", extending over several 'long' winter months, as previously reported (1, 2) for the same geographic region as that figuring in the present study.
The pineal hormone melatonin is thought to play an important role in the circadian and seasonal regulation of sleep and many other biological rhythms. Melatonin is mainly secreted during the night and is alleged to act as a "darkness signal". Some studies have revealed seasonal variations in melatonin secretion patterns (3) (4) (5) (6) (7) . Light at night suppresses melatonin secretion. Photoperiodic alterations in the secretion during the year are significantly influenced by latitude (4). Seasonal complaints increase with distance from the Equator and it is believed that some people are vulnerable to these fluctuations in day length (8, 9) . Phase delay of melatonin rhythms in SAD (10) and insomniac patients have been reported (11) .
In previous studies, patients with insomnia during the "dark period" in northern Norway were investigated in explorative, controlled trials with drugs (12) and light treatment (1) and their serum melatonin and cortisol levels were determined before and after artificial light treatment (2) .
To study changes in the natural light-dark conditions in the region, we followed a group of individuals who complained of insomnia du-ORIGINAL RESEARCH ring the dark period and a control group of healthy individuals, from the beginning of January until the vernal equinox in March. Blood samples were studied for morning and evening melatonin levels and sleep questionnaires were completed during the dark period and after the sunlight had reappeared.
The main purpose of the study was to investigate changes in melatonin levels and reported sleep problems during the rapid dark-light shift from January to the vernal equinox in March.
MATERIAL AND METHODS

Material
The insomnia patient group consisted of seven individuals (five men and two women) who complained of sleep difficulties during the dark winter period. The mean age was 38, with a range of 20-64 years. The control group consisted of seven individuals (three men and four women) who reported that they slept normally during the dark period. The mean age was 29, with a range of 21-44 years.
Sunlight conditions
The rapid increase in environmental light during the study period is illustrated by the number of hours of sunlight for each month as recorded by The Norwegian Meteorological Institute, Forecasting Division for Northern Norway at the Tromsø latitude of 69º N: in January 5.6 h, in February 20.8 h, and in March 86.5 h.
Clinical assessments
Individuals in the insomnia patient group were recruited after reading information in the media about ongoing studies at our hospital concerning sleep problems in the dark period. Individuals in the control group consisted of staff at the hospital and some of their family members and friends.
All individuals were screened using a questionnaire with the following 10 items:
1.
Time for going to bed, 2.
Sleep latency, 3.
Sleep interruptions, 4.
Total sleep time,
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5.
Wake onset, 6.
Sleep need, 7.
Sleep depth, 8.
Sleep quality. We also used two visual analogue scales (VAS) relating to: 9.
Tiredness at bedtime (VAS p.m. ) and 10. Tiredness in the morning (VAS a.m. ). The VAS was a self-evaluated, 100-millimetre scale with endpoints "no tiredness" and "extreme tiredness".
During the study, all subjects filled in the self-rated questionnaire relating to the upcoming night, in the evening while blood samples were taken. The next morning, again during the collection of blood samples, they completed the 10-item questionnaire relating to the previous night.
All individuals were interviewed before the study and none of the participants had any apparent, or known psychiatric, or somatic disease. None of the individuals used medication, or drank alcohol during the days, or nights, before sampling.
Melatonin assay
Blood samples for melatonin analysis were collected in the evenings and the following mornings on the dates Jan. (13) . The lower limit of detection was 0.01 nmol/l. The intra-assay coefficient of variance (CV) was 7.4 % and the inter-assay CV for samples (N = 60) above 0.15 nmol/l was 4.8 %.
Statistical analysis
To capture potential changes in evening and morning melatonin over the different dates, from the 9 th -10 th of January until the19 th -20 th of March, we used three different statistical measures of melatonin. One estimate of melatonin was to calculate the Mean ± Standard Error of the Mean (SEM) of the three time points in the evening and of the two time points in the morning. Another estimate of melatonin was to calculate the Mean ± Standard Deviation (SD) of the area under the curve (AUC). The third was to determine the Mean ± SD of the ma- 
RESULTS
Correlations
The melatonin levels at the times 22:00, 22:45 and 23:30 were correlated, as were those at 07:30 and 08:15 (p < 0.01). A positive correlation was found between Mtmax, as well as morning values of MT AUCmorning , and morning tiredness in group 1 (rho = 0.39, p < 0.05 and rho = 0.48, p < 0.01, respectively). No other items of sleep correlated with single melatonin levels (at the different time points), MTmax, MT AUCevening , or MT AUCmorning .
Comparisons between patients and controls of melatonin levels at different time points and dates Individuals in the insomnia patient group had lower melatonin levels, 0.11 ± 0.02 (Mean ± SEM) at 23:30 h compared to controls 0.18 ± 0.09, (p < 0.01) on January 9 th -10 th (Figure 1a ).
On the 30 th -31 st of January, individuals in the insomnia patient group also had lower levels of melatonin than individuals in the control group at 23:30 h (0.16 ± 0.07; 0.32 ± 0.13, respectively, p < 0.05) (Figure 1d ).
Comparisons within patients of melatonin levels at different time points and dates
The melatonin level (mean ± SEM) was significantly lower at 23:30 h when comparing the dates Jan 9 th -10 th (0.11 ± 0.08) with Jan 30 th -31 st (0.32 ± 0.13; p < 0.01) (Figure 1a and 1d) . (Figure 1a and 1e) . The control group also showed a tendency of phase advance when light returned during the later half of January (Figure 1c and 1d) as compared with the insomnia patient group.
The control group had a significantly higher Mtmax on the 23 rd -24 th of January as compared with Mtmax in March (Table I) .
Comparison between means of sleep variables
The VAS scores for 'morning tiredness decreased significantly in the control group, but not in the insomnia patient group, when comparing the VAS a.m. on the 9 th -10 th of January with the VAS a.m. in March.
When comparing the mean VAS a.m. of the four dates in January with the VAS a.m. in March, a significantly lower level. was found in when compared with individuals of the control group (see Table I ). We thus found that the rapid change in environmental lighting conditions, at the time period when daylight returned on the 21 st of January, was related to an increase in melatonin in both the insomnia patient group and the control group. All three statistical measures, i.e. the mean of evening and morning melatonin levels separately, the AUC and the Mtmax, gave very similar results with a correlation coefficient > 0.98. In this paper, we have presented the MTmax and selected sleep variables in Table I and the mean melatonin levels in Figure 1 , Figure 2 and Figure 3 .
ORIGINAL RESEARCH DISCUSSION
The present study was unique in the sense that natural light-dark conditions were investigated from complete lack of daylight (0 h) in the middle of January, to 12 h of sunlight per 24 h (at the end of March). Using three statistical measures of melatonin (mean melatonin evening and morning levels, AUC and MTmax) gave very similar results in this pilot study. However, with a more complex research design and more time points, it may be of crucial importance to examine the data with all three measures, i.e. variables emphasizing different aspects of the endocrine changes. This becomes even more important when several variables are included in the study (15, 16) .
The time-points of the melatonin assays in this study are discontinuous and do not include the night-time measures (1-3 hrs) during which, under "normal" conditions, the nocturnal peak secretion of melatonin occurs. However, by repeated measures of melatonin on different dates and during the period of time when there is a considerable change in dark-light conditions, we believe that potential changes in phase and amplitude will be detected with late evening and early morning measures.
The investigation was performed during a limited, three-month period of the year and we were, thus, able to limit the variation in subjective reports, which may occur in individuals within the subarctic region. Lund and Hansen (9) studied the average ratings for seasonal affective symptoms of 200 individuals in northern Norway using a Seasonal Pattern Assessment Questionnaire and found that reported symptoms differed according to the season in which the questionnaire was completed. The average score for seasonal affective disorder changed over the year, with the highest score in March and the lowest in September.
The significant rise in melatonin during the middle of January is rapid and of short duration. This was obviously not detected in another study of melatonin and season, when only monthly sampling of urine was analysed for melatonin concentration (4), but it agrees with the experimental results of Midwinter et al. (17) and Owen et al. (18) . They found that the effect of light on melatonin was more efficient in the latter part of the night in winter and this was particularly documented for the effect of dim light.
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The significant decrease in melatonin when hours of sunlight return to Tromsø in January may be explained by a shift of timing for melatonin onset.
Given that the endogenous circadian period of the human circadian pacemaker is slightly longer than 24 h, the findings suggest that a naturalistic dawn signal is sufficient to prevent this natural delay drift. Zeitgeber transduction and circadian system response may be tuned to the time-rate-of-change of naturalistic twilight signals, as recently reported in an experimental study by Danilenko et al. (19) . Actually, the same research group (20) showed that, under controlled conditions of a modified constant routine protocol, a single dawn signal was sufficient to phase advance the timing of the onset of secretion of melatonin. The significant phase advance of melatonin was enhanced from 20 to 34 minutes after three consecutive dawn signals. This is small but appears to be of sufficient magnitude to entrain the human circadian pacemaker, which has an endogenous period of about 24.2 h. Individuals in both the insomnia patient group and the control group reported morning tiredness in January, while individuals of the control group reported a decrease in morning tiredness with increasing day length and hours of sunshine. However, the insomnia patients still had sleep problems in March and, in particular, reported that they still experienced morning tiredness. This may be due to an endogenous vulnerability of this group of persons in their ability to adapt their internal biological rhythm to the rapid light change during the last part of January. This was demonstrated by a slower return of the higher melatonin secretion in the morning to the higher and "normalised" secretion of melatonin during night-times in March, as compared with individuals without sleep problems. The finding of a significant correlation of morning tiredness and morning melatonin is in line with the finding of a slower adaptation to the rapid external light changes in insomnia patients.
Therefore, it is conceivable that individuals with sleep problems during the dark period may benefit from treatment with light, or from oral melatonin administration.
Both individuals with sleep problems and controls reported morning tiredness in January. One possible reason for the group difference may be differences in exercise patterns, as Weydahl (21) has shown that melatonin levels in January are influenced by hours of ORIGINAL RESEARCH habitual exercise during the autumn among individuals living in a sub-arctic region in Norway. Another possible explanation may be different sensitivities of retinal light receptors between the two groups -a hypothesis that may now be tested. This explanation is interesting in light of the recent finding by Lucas et al. (22) , who suggested the existence of a melanopsin-associated system, complementary in function to the classical rod/cone system.
Other possible underlying mechanisms may also participate in the regulation of the sleep-wake cycle, as recently reviewed by Lavie (23) .
